Variant report
Variant | esv3387825 |
---|---|
Chromosome Location | chr1:209433029-209437127 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:209436086..209438549-chr1:209440890..209443254,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000225712 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs560583735 | chr1:209433060-209433061 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs527667169 | chr1:209433145-209433146 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs115283316 | chr1:209433160-209433161 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs374352030 | chr1:209433164-209433165 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs373400320 | chr1:209433166-209433167 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs116371472 | chr1:209433199-209433200 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs191188036 | chr1:209433200-209433201 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs550399452 | chr1:209433231-209433232 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs183492307 | chr1:209433234-209433235 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs147014485 | chr1:209433246-209433247 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs554365228 | chr1:209433260-209433261 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs376818807 | chr1:209433279-209433280 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs566491401 | chr1:209433314-209433315 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs77329914 | chr1:209433367-209433368 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs77805004 | chr1:209433374-209433375 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs576730258 | chr1:209433458-209433459 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs544061858 | chr1:209433507-209433508 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs34915400 | chr1:209433525-209433526 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs554042519 | chr1:209433552-209433553 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs34998894 | chr1:209433612-209433613 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs555981452 | chr1:209433686-209433687 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs574291451 | chr1:209433699-209433700 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs188344646 | chr1:209433700-209433701 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs560370739 | chr1:209433737-209433738 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs527754976 | chr1:209433759-209433760 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs201556649 | chr1:209433760-209433761 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs545896794 | chr1:209433766-209433767 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs564423803 | chr1:209433797-209433798 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs35594247 | chr1:209433810-209433811 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs532050770 | chr1:209433830-209433831 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs550484334 | chr1:209433887-209433888 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs192290516 | chr1:209433970-209433971 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs529443337 | chr1:209434055-209434056 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs570902033 | chr1:209434077-209434078 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs548300324 | chr1:209434089-209434090 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs139238247 | chr1:209434090-209434091 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs566460151 | chr1:209434153-209434154 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs2800932 | chr1:209434184-209434185 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs112905661 | chr1:209434192-209434193 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs570105290 | chr1:209434201-209434202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs537796224 | chr1:209434243-209434244 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs183163222 | chr1:209434284-209434285 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs187894717 | chr1:209434290-209434291 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs535309511 | chr1:209434352-209434353 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs543163317 | chr1:209434361-209434362 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs374528140 | chr1:209434375-209434376 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs191154935 | chr1:209434426-209434427 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs553906538 | chr1:209434459-209434460 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs377276441 | chr1:209434509-209434510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs546276327 | chr1:209434519-209434520 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21611746 | CNVD |
Breast cancer | 17393978 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chordoma | 18071362 | CNVD |
Macular degeneration | 22558131 | CNVD |
Alzheimer''s disease | 21403675 | CNVD |
Multiple myeloma | 16461302 | CNVD |
van der Woude syndrome | 22470819 | CNVD |
van der Woude syndrome | 20818247 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 17060936 | CNVD |
Atypical hemolytic uremic syndrome | 19861685 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Urothelial tumor | 18831757 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 20406844 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:209424800-209439600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr1:209432400-209434200 | Enhancers | Hela-S3 | cervix |
3 | chr1:209433600-209433800 | ZNF genes & repeats | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr1:209433800-209441000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
5 | chr1:209434200-209437600 | Weak transcription | Hela-S3 | cervix |